These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24861337)

  • 1. Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
    Ignatowski TA; Spengler RN; Dhandapani KM; Folkersma H; Butterworth RF; Tobinick E
    CNS Drugs; 2014 Aug; 28(8):679-97. PubMed ID: 24861337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on: "Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence".
    Whitlock DR
    CNS Drugs; 2014 Dec; 28(12):1205-6. PubMed ID: 25373628
    [No Abstract]   [Full Text] [Related]  

  • 3. Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
    Ignatowski TA; Spengler RN; Tobinick E
    CNS Drugs; 2014 Dec; 28(12):1207-13. PubMed ID: 25373629
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
    Tobinick E
    CNS Drugs; 2011 Feb; 25(2):145-55. PubMed ID: 21254790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.
    Tobinick E; Kim NM; Reyzin G; Rodriguez-Romanacce H; DePuy V
    CNS Drugs; 2012 Dec; 26(12):1051-70. PubMed ID: 23100196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid improvement in severe long COVID following perispinal etanercept.
    Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
    Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate neurological recovery following perispinal etanercept years after brain injury.
    Tobinick E; Rodriguez-Romanacce H; Levine A; Ignatowski TA; Spengler RN
    Clin Drug Investig; 2014 May; 34(5):361-6. PubMed ID: 24647830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perispinal etanercept: potential as an Alzheimer therapeutic.
    Griffin WS
    J Neuroinflammation; 2008 Jan; 5():3. PubMed ID: 18186919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
    Tobinick E
    Medscape J Med; 2008 Jun; 10(6):135. PubMed ID: 18679537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2012 Jan; 9(1):99-109. PubMed ID: 22191562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
    Tobinick EL; Gross H
    BMC Neurol; 2008 Jul; 8():27. PubMed ID: 18644112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.
    Tobinick E
    CNS Drugs; 2009 Sep; 23(9):713-25. PubMed ID: 19689163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perispinal etanercept for treatment of Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2007 Dec; 4(5):550-2. PubMed ID: 18220520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
    Tobinick EL; Gross H
    J Neuroinflammation; 2008 Jan; 5():2. PubMed ID: 18184433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perispinal TNF-alpha inhibition for discogenic pain.
    Tobinick EL; Britschgi-Davoodifar S
    Swiss Med Wkly; 2003 Mar; 133(11-12):170-7. PubMed ID: 12715286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perispinal etanercept: a new therapeutic paradigm in neurology.
    Tobinick E
    Expert Rev Neurother; 2010 Jun; 10(6):985-1002. PubMed ID: 20518613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Peripheral TNF-α and Downregulation of Microglial Activation by Alpha-Lipoic Acid and Etanercept Protect Rat Brain Against Ischemic Stroke.
    Wu MH; Huang CC; Chio CC; Tsai KJ; Chang CP; Lin NK; Lin MT
    Mol Neurobiol; 2016 Sep; 53(7):4961-71. PubMed ID: 26374550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perispinal etanercept for neuroinflammatory disorders.
    Tobinick E
    Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
    Tobinick E; Davoodifar S
    Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic.
    Clark IA
    Pharmacol Res Perspect; 2022 Apr; 10(2):e00926. PubMed ID: 35174650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.